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Abstract 1 
Background. Chronic hepatitis B virus (HBV) frequently causes liver disease, and early identification 2 
can improve outcome.  The burden of chronic HBV infection in many economically developed 3 
nations lies in migrant populations.  Targeted HBV testing of migrants, and contact tracing for those 4 
diagnosed, are public health objectives, but uptake has been fragmentary.    This qualitative study 5 
aimed to investigate understanding of hepatitis B and response to testing and contact tracing 6 
amongst people of Somali ethnicity living in Bristol, UK. 7 
Methods. The views of 30 people of Somali ethnicity living in Bristol were explored through focus 8 
groups and semi structured interviews.  Transcripts of audio-recorded interviews and focus groups 9 
were imported into NVivo10 and inductive thematic analysis undertaken. 10 
Results.  Most participants lacked awareness of hepatitis B, and often co-identified hepatitis B with 11 
‘jaundice’. There were frequent misconceptions regarding transmission, natural history and 12 
diagnosis, with hepatitis B commonly viewed as a relatively trivial, short lived, symptomatic disease. 13 
Hepatitis B was generally not stigmatised.  Lack of understanding of the disease was cited as the 14 
major barrier to targeted testing and contact tracing.   15 
Conclusion. These findings suggest public health initiatives to promote hepatitis B testing and 16 
contact tracing within migrant Somali populations should focus on improving hepatitis B 17 
understanding, particularly its natural history and diagnosis, and avoid translation of ‘hepatitis B’ 18 
into terms meaning ‘jaundice’ to address misperception of low susceptibility and low severity. 19 
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Introduction 1 
Chronic hepatitis B virus (HBV) infection frequently causes cirrhosis and liver cancer. Early diagnosis 2 
can improve outcome through hepatocellular carcinoma (HCC) surveillance and antiviral therapy. 3 
HCC surveillance increases survival (1, 2), while antiviral therapy improves surrogate markers of 4 
disease progression and is expected to demonstrate improved survival (3). In addition early 5 
diagnosis can prevent onward transmission through vaccination of contacts (4). 6 
In many developed nations, including the UK, the burden of chronic HBV infection lies within migrant 7 
communities, and screening of migrants for HBV is recommended (5-9).  The cost effectiveness 8 
ofHBV screening depends on adequate uptake of testing and engagement with monitoring, 9 
treatment and vaccination, which have been poor in migrant communities (10-17). Engagement of 10 
migrant populations with health services has been shown to be affected by a number of common 11 
factors, including accessibility and language services, but qualitative studies have also identified 12 
culture specific understanding of hepatitis B as an important determinant of engagement (18-34). 13 
 As only approximately 15-25% of people with chronic HBV infection develop liver cirrhosis or HCC, 14 
many of those diagnosed derive limited health benefit from their diagnosis and can experience harm 15 
through anxiety and time lost to consultations. In societies where the disease is stigmatised the 16 
harms can be significant and may outweigh the benefits for some individuals. Significant stigma has 17 
been described in West African migrants in USA (28-32), and indigenous Ghanaians (35), as well as a 18 
number of Asian migrant populations (27, 34). 19 
Thus to ensure cost effectiveness of HBV screening and to avoid harm a clear understanding of 20 
cultural attitudes to hepatitis B in migrant populations is required.  In this paper we report the 21 
findings of a qualitative study that examined knowledge and perceptions of hepatitis B in a migrant 22 
Somali population.  We chose to study a single ethnic group in order to achieve greater depth of 23 
enquiry into culture specific determinants of understanding of hepatitis B, including exploration of 24 
the role of language in perpetuation of misconceptions. The aim was to provide information to 25 
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foster culturally appropriate implementation of HBV screening and contact tracing to maximise 1 
engagement and minimise harm.    We chose to study a Somali migrant population as, compared to 2 
West African and Asian populations, studies exploring the East African cultural understanding of 3 
Hepatitis B have been limited (27-34).  Also, significant Somali migrant populations are present in a 4 
number of nations were hepatitis B testing is recommended, including USA, Canada, Netherlands 5 
and UK.   6 
Approximately 97,000 people born in Somalia are living in the UK with large populations in London, 7 
Liverpool and Bristol where this study was based (36, 37).  The Bristol Somali population numbers 8 
around 7,000 with a HBV prevalence of 2.9% (38) and was chosen for this study as the city hosts a 9 
strong community health advocacy enterprise which was expected to optimise study engagement.  10 
 11 
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Methods 1 
Data was collected using qualitative research methods between February and July 2014. Adults of 2 
Somali ethnicity living in Bristol UK, were recruited through informal community networks by Somali 3 
community health advocates.  Purposive sampling taking account of gender, age, levels of education, 4 
duration living in the UK and employment status was used to select participants to capture variation 5 
in views and experiences.  6 
Recruits reporting that they had not previously been diagnosed with HBV infection were invited to 7 
participate in one of four focus groups which were organised separately for women (focus groups 1 8 
and 2) and men (focus groups 3 and 4) and each comprised 4 to 8 recruits. Focus groups 1 to 3 were 9 
held in Somali with the assistance of an interpreter, focus group 4 was held in English. The focus 10 
groups explored the participants understanding of hepatitis B, and used targeted screening and 11 
contact tracing scenarios to understand barriers and triggers to engagement.  12 
Recruits reporting that they had been previously diagnosed with hepatitis B infection were invited to 13 
participate in one-to-one interviews which aimed to explore their experiences of hepatitis B 14 
infection.  Topic guides, informed by the Health Belief Model (39) were used to facilitate the focus 15 
group discussions and semi-structured interviews so perceived susceptibility and severity of hepatitis 16 
B, barriers and benefits, and cues to action as they related to hepatitis B testing could be explored. 17 
Focus groups and interviews lasted approximately 1 hour, and were conducted in community 18 
centres convenient for participants.  19 
Focus groups and interviews were audio recorded, transcribed, anonymized, checked for accuracy 20 
and then imported into the software package NVivo10. Data collection and analysis were conducted 21 
in parallel and continued until data saturation in major themes was reached (40). Data-driven 22 
inductive thematic analysis (41), was used to scrutinise the data in order to identify and analyse 23 
patterns across the dataset using constant comparison techniques (42). Transcripts were examined 24 
on a line-by-line basis and an initial coding frame developed by AC. A subset of transcripts was 25 
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independently analysed by JH to contribute to the generation and refinement of codes and thematic 1 
categories to maximize rigor. 2 
All participants received written and verbal information about the research and provided written 3 
informed consent. Ethical approval for the study was obtained from the NHS National Research 4 
Ethics Service Committee London - Camden & Islington 13/LO/11/80. 5 
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  7 
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Results 1 
A total of 49 adults were approached of whom 30 participated. The mean age of participants was 50 2 
years (range 32 to 71), 17 were women, 28 spoke Somali as their first language and all were Muslim.  3 
Participants varied in relation to education, language ability and hepatitis B exposure (Table 1).  The 4 
analysis identified key themes which are illustrated below with the use of anonymised transcript 5 
extracts (Tables 2 to 4). Additional relevant extracts are provided as supplementary material.  In the 6 
extracts ‘. . .’ indicates that words from the original verbatim quote have been omitted (repetition, 7 
digressions or unclear speech).  Participants are identified by a pseudonym (A to H), and a focus 8 
group (number 1 to 4) or an interview (letter ‘i’).  9 
Awareness, understanding and stigma of hepatitis B  10 
Most participants were not familiar with the English language term ‘hepatitis B’ (Table 2).  This 11 
included some who spoke English and had a high level of formal education.  A minority of 12 
participants, particularly those who knew someone diagnosed with hepatitis B in Europe, had an 13 
appreciation of its major characteristics but felt that the disease was not well understood in the 14 
Somali community (Table 2 and supplementary data). 15 
The few participants who were familiar with the term ‘hepatitis B’ often explained it within their 16 
group using the English term ‘jaundice’ or the Somali terms ‘Joonis’, ‘Cagaarshow’ and ‘agaarhou’ 17 
meaning yellowing or greening of the skin and eyes.  Some participants used the terms hepatitis B 18 
and jaundice interchangeably, while others became confused about the use of the two terms (Table 19 
2 and supplementary data). 20 
When asked about the cause of hepatitis B (which had already become co-identified with jaundice 21 
within the groups), a change in diet or excess fatty food was most commonly voiced (Table 2).  22 
Drinking unclean water was also suggested, and three English speaking participants mentioned a 23 
virus or bacteria (there is no word in Somali for virus, bacteria or germ).  When asked about 24 
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transmission, the majority who responded said they didn’t know how HBV was transmitted or how 1 
to prevent transmission, while a few suggested it was transmitted by poor sanitation, sexual routes, 2 
blood transfusion or sharing food (Table 2).    3 
The focus group participants were unanimous that hepatitis B was not stigmatised in Somali culture, 4 
and none of the four participants interviewed (who had been diagnosed with Hepatitis B) indicated 5 
that they had felt stigmatised by their diagnosis.  One interview participant suggested that though 6 
jaundice was not traditionally stigmatised in Somalia, he felt that as people began to understand 7 
more about it stigma was beginning to emerge (Table 2). 8 
Response to public health messages  9 
To explore targeted screening of migrants, examples of posters and letters (in English and Somali) 10 
recommending hepatitis B testing of people born in high prevalence countries were discussed. 11 
Participants were asked to consider how UK Somali’s would respond to the health messages 12 
provided.   The general response was positive, with all groups indicating that Somali’s would have a 13 
desire and duty to look after their health and that of their family (Table 3).   14 
There was consensus that the majority of UK Somali’s would not engage with hepatitis B posters, but 15 
that a letter directly sent to them would usually prompt them to seek further information and 16 
testing, (Table 3 and supplementary data).  Reasons given for not attending for testing included 17 
misconceptions of the nature of hepatitis B.  For example, the misconception that ‘jaundice’ (and by 18 
association hepatitis B) was a relatively trivial disease without long term consequences was 19 
consistent across all focus groups (supplementary data), and was cited as a deterrent to testing and 20 
to engagement with the information provided.   21 
 22 
Misconceptions regarding the transmission route and natural history of the disease were also cited 23 
as deterrents, with participants saying that some people in their community would feel that they 24 
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couldn’t have ‘jaundice’ (and thus hepatitis B) if they had a good diet, or had no symptoms (Table 3).  1 
Finally, a number of participants said they believed that an unrelated visit to the doctor, some 2 
general blood tests or other health screening would pick up hepatitis B, and that this would deter 3 
testing. 4 
In both the male focus groups participants expressed the view that Somali people would be 5 
suspicious of a public health intervention targeting a single racial group, and would find this 6 
stigmatising.  An intervention targeted more widely was acceptable (Table 3).  7 
Response to contact tracing was explored through the scenario of a newly diagnosed Somali who is 8 
informed by his/her GP of the transmission routes, and advised that his/her partner, children and 9 
other family members living in the same house should be tested and vaccinated.  There was 10 
consensus that the person with hepatitis B has a strong duty to disclose given that the disease is 11 
transmissible, and that telling their contacts that they had hepatitis B (or jaundice) would be easy as 12 
there is no stigma or embarrassment associated with the disease (Table 3). This expectation was 13 
backed up in the one-to-one interviews where all participants asked (three of the four) said they had 14 
disclosed to their family.   15 
While it was considered easy to disclose the diagnosis, there was consensus that explaining the 16 
transmission routes and the risk of cirrhosis or cancer would be difficult, as these would not concur 17 
with expected attributes of ‘jaundice’ (Table 3).  Again, this difficulty was confirmed by the 18 
interviewees.   19 
An additional theme that emerged from the female focus groups was concern that male partners 20 
might not attend for testing and vaccination (supplementary data).  Reasons given were that if the 21 
man was healthy, he wouldn’t feel he needed to go, or that he was likely to believe that his health 22 
had already been checked, or that men in general are reluctant to go to the doctor. The idea that 23 
men would not take the risk seriously was also expressed by one of the interview participants (Table 24 
3).  25 
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In the male focus groups there was acknowledgement that women would be more concerned than 1 
men, but the majority voice was that most male Somali contacts would attend for testing and 2 
vaccination. When asked why some male contacts might not go, the only reason volunteered was 3 
lack of understanding (supplementary data).   4 
Overcoming barriers to engagement 5 
When asked what would increase engagement with testing and contact tracing, ‘information’ was 6 
suggested most frequently across all focus groups.  Where the facilitator questioned whether 7 
information alone would be sufficient to reverse misconceptions, it was felt that it would.  For 8 
example, regarding symptoms, there appeared to be no conceptual resistance to the possibility of an 9 
asymptomatic disease, rather symptoms were expected for this particular disease (‘jaundice’). 10 
 11 
The most effective media for delivery of information was discussed.  To increase awareness of 12 
hepatitis B, radio, television and group discussions were suggested as useful, with oral 13 
communication generally regarded as more effective than written (Table 4).  To attract people for 14 
testing,  the consensus was that letters addressed to individuals would have a big impact so long as 15 
they were translated properly into Somali (Table 4), and that people could be supported to attend by 16 
talking to a member of the Somali community who had experience of hepatitis B (supplementary 17 
data). Other written information was also valued, particularly during the process of contact tracing 18 
where a proposal to supply the index case with written information for the contact was welcomed 19 
(supplementary data).  20 
Regarding information content participants emphasised that sufficient information should be 21 
presented so the person can understand the disease and overcome their misconceptions.  The 22 
information most commonly cited as important was that hepatitis B could result in a serious or fatal 23 
outcome (Table 4).  Participants were also concerned that information regarding targeted testing of 24 
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migrants should be explicit in the inclusion of migrants from a number of continents not just Africa in 1 
order to avoid generation of stigma against Africans. 2 
Discussion 3 
This study explored understanding of hepatitis B and response to targeted screening and contact 4 
tracing from the perspective of a UK migrant Somali population.  To our knowledge this study is the 5 
first to address these issues in a Somali population.  Strengths of the study include the diverse 6 
background and demographic of our participants, and the use of interpreters to explore the opinions 7 
of non-english speaking participants.  Limitations include the restricted geographic area for 8 
recruitment. 9 
We found no common cultural understanding of hepatitis B.  Of interest, participants who initially 10 
had no understanding of hepatitis B, came to co-identify hepatitis B with jaundice both through 11 
explanations from other group members, and through translation of hepatitis B into words meaning 12 
jaundice by interpreters.  This progression occurred in all the focus groups, and is likely to be 13 
reflected outside the research setting as translation of ‘hepatitis B’ into terms meaning jaundice is 14 
common in medical interpretation and in currently available patient information leaflets in print and 15 
on line (43, 44).  As jaundice (and the Somali terms ‘joonis’, ‘cagaarshow’ and ‘agaarhou’), indicates 16 
having yellow skin or eyes, this co-identification is in direct conflict with the largely asymptomatic 17 
nature of hepatitis B.  Given migrant screening and testing of contacts aims to diagnose the infection 18 
during its asymptomatic phase, co-identification with jaundice may be a barrier to testing.   19 
A number of the other misconceptions we observed may be based on experience of other diseases 20 
causing jaundice. For example, hepatitis A, which is a common cause of jaundice in Somalia, is 21 
transmitted through unclean food and water, and is usually a relatively trivial disease from which 22 
recovery is complete.  Lack of awareness and diverse understandings of hepatitis B, including some 23 
of the concepts reported here, have been described in previous studies of migrant populations (27, 24 
13 
 
45), but the key role of translation of ‘hepatitis B’ into words meaning ‘jaundice’ in generation of 1 
misconceptions has not previously been suggested.  2 
The Health Belief Model (39)  components of perceived susceptibility and severity,  perceived 3 
benefits, barriers, and cues to action, have been used to explain why individuals’ decide, or not, to 4 
attend hepatitis B screening across diverse ethnic groups, (46) (47).  We found that the Bristol 5 
Somali population voiced factors cognisant with perceived susceptibility and severity as major 6 
influences on decisions regarding testing.  Thus the perceived non-susceptibility associated with lack 7 
of symptoms, a healthy lifestyle and previous health checks; and the perceived non-severity of 8 
‘jaundice’ were all cited as deterrents to testing in our study.  In terms of perceived benefit, the 9 
ability to protect their family through vaccination was voiced as highly valued.  Structural and 10 
cultural barriers to testing were not prominent, with the overriding opinion being that if 11 
misperceptions regarding susceptibility and severity could be overcome, then testing would be 12 
sought. 13 
Our findings suggest that public health initiatives to promote hepatitis B testing in Somali migrant 14 
populations should prioritise provision of clear information about the natural history of hepatitis B 15 
to address misperception of low susceptibility and low severity, and should be cognisant of the role 16 
of language in creation and perpetuation of misconceptions.  Specifically, patient information 17 
provided for Somalis should avoid translation of the term ‘hepatitis B’ into terms meaning jaundice, 18 
should acknowledge but refute the erroneous co-identification of hepatitis B with jaundice, and 19 
should emphasise the following points: 1) hepatitis B is usually asymptomatic; 2) hepatitis B can 20 
affect you whatever your diet and lifestyle; 3) hepatitis B can cause severe illness; 4) standard health 21 
checks and blood tests will not pick up hepatitis B.  Regarding the delivery of information, the 22 
preference indicated in our focus groups for oral and community based methods is in keeping with 23 
the strong oral tradition within Somali culture, and suggests that radio, TV, community discussion 24 
groups and opportunistic conversation with health professionals would be preferred methods. 25 
14 
 
Community health education has been successful in other public health initiatives in Somali 1 
communities in the UK (48).  2 
 3 
Our observations highlight that clear written information may be beneficial for people newly 4 
diagnosed with hepatitis B, to help them explain to their contacts the rationale behind testing and 5 
vaccination. Studies of hepatitis B contact tracing generally show poor uptake (14-17), indicating 6 
room for significant public health benefit.   7 
Unlike the qualitative research observations in West African populations where stigma towards 8 
hepatitis B was a barrier to screening, and a cause of non-disclosure (28, 31), our findings suggest 9 
that hepatitis B is not a stigmatised disease in the Somali community in Bristol, and stigma is not a 10 
factor influencing testing or disclosure.  We found some concern that hepatitis B may become 11 
stigmatised as knowledge increases, and, as stigma has been negatively associated with testing in 12 
other migrant communities (25, 26, 45), care should be taken to avoid undue emphasis of potentially 13 
stigmatising aspects of the disease.  Of more concern to our participants was that targeted testing of 14 
migrants could stigmatise the targeted communities.   Recent prevalence data suggests that 15 
narrowing the target migrant population for screening by country of birth may be justified on cost 16 
effectiveness grounds (38) increasing the potential for stigmatisation.   17 
In conclusion, this study suggests that migrant Somalis in a large UK city feel a duty to look after their 18 
health and that of their family, but have low awareness and understanding of hepatitis B, tend to 19 
discuss hepatitis B using terms meaning ‘jaundice’, and harbour a number of disease 20 
misconceptions.  The lack of awareness and misconceptions represent likely barriers to engagement 21 
with targeted screening and contact tracing which could be addressed through provision of culturally 22 
appropriate information.  The likely role of translation in generating misconceptions should prompt 23 
a wider assessment of the knock on effects of the specific terms used in medical interpretation. 24 
15 
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Key points 13 
• This study suggests that lack of awareness and misconceptions of hepatitis B are major 14 
barriers to testing in migrant Somalian populations.   15 
• Perceived non-susceptibility and non-severity emerge as important disincentives to testing. 16 
• Public health initiatives to raise awareness and knowledge should be careful to avoid 17 
increasing misconceptions and introducing stigma.   18 
• Particular attention should be paid to language in order to avoid co-identification of 19 
hepatitis B with jaundice.   20 
• The current lack of stigma and strong cultural duty of care for the family facilitates contact 21 
tracing in this population.   22 
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 1 
Participants characteristics 
Focus 
group 
participants 
Interview 
participants 
Gender Male 14 3 
Female 12 1 
Age Category (years) 25-34 3 0 
35-44 7 1 
45-54 6 0 
55-64 5 2 
65-74 3 1 
unknown 2 0 
Duration of residence in UK More than 5 years 16 4 
5 years or less 4 0 
Not recorded 6 0 
Marital status Married 17 2 
Single 5 2 
Divorced 1 0 
Not Recorded 3 0 
Current employment status Employed 6 1 
Unemployed 19 3 
Not recorded 1 0 
Highest level of formal education No formal education 3 2 
Left school before completing secondary 
level 
5 0 
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Completed secondary education or 
vocational training 
7 0 
Completed university or college 9 2 
Not recorded 2 0 
English language ability No Verbal or written understanding 4 1 
Some verbal or written understanding 8 3 
Good verbal and written understanding 14 0 
Ever tested for hepatitis B Yes 8 4 
No 12 0 
Not recorded 6 0 
Ever diagnosed with hepatitis B 
infection 
Yes 1 4 
Knows anyone who has been 
diagnosed with hepatitis B 
infection. 
Yes 4 1 
No 15 3 
Not recorded 7 0 
Table 1. Demographics, educational background and hepatitis B testing history of participants. 1 
 2 
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Theme Illustrative quote 
Understanding 
of hepatitis B 
and  
co-
identification 
or confusion 
with jaundice 
Facilitator: “So first of all, I just wonder whether any of you have any ideas about 
hepatitis B, what it is, what it causes?” 
Mrs B2: “We don’t know.” 
Facilitator: “And you?” 
Mrs ?2: “Me too.” 
Mrs F2: “Is it not like asthma, or something like that, linked up with that?” 
Mrs H2: “I think of the liver… more than asthma.” 
Mrs?2:  “Maybe fat or something ” 
Mrs D2: “I think it causes the kid’s headache and temperature.” 
Mrs B2: “We used to have it in Somalia, it is jaundice, it affects the liver” 
…. 
Mrs E2: “we had a family history of hepatitis B, some people say jaundice, some 
people say hepatitis B” 
Mr F3 “This [hepatitis B] is a disease that people know very little about, not so 
common as other like TB.” (Man with experience of hepatitis B).  
Facilitator: “Ok, do you know or do you think there is any treatment for hepatitis 
B, have you heard of any treatment?”….. 
Mrs ?2 “We are getting confused between jaundice and hepatitis B.” 
Cause and 
transmission 
of hepatitis B 
or ‘jaundice’ 
Mr Di: “The cause is malnutrition, constipation, and when someone is 
malnourished and then all of a sudden starts taking meat or fatty things, it is 
fatal, as long as you don’t have the constipation and are healthy in that way, you 
don’t catch it.” 
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Facilitator: “And do you know any way that hepatitis B can be transmitted, from 
one person to another? You have mentioned about food in the refugee camps.” 
Mr A4:“I don’t know, I don’t think it is transmissible, I don’t know.”  
Mr ?4 “It is sexually transmitted isn’t it?”  
Mr E4: “If you get blood, blood transfusion.”   
Mr A4: “And by food as well?” 
Facilitator: “..do you know of any ways that you can stop yourself from getting 
hepatitis B?” 
Mrs B1: “No.”  
Mrs C1: “No idea.”  
Mrs D1: “No”. 
Diagnosis of 
hepatitis B 
Mr Ai: “when we arrived at this country we had all health screening, and I think 
they could have picked up something if there was hepatitis B”. 
Table 2. Quotes illustrating awareness and understanding of hepatitis B and its diagnosis.  1 
  2 
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Theme Illustrative quote 
Response 
to 
targeted 
hepatitis 
B 
screening 
Facilitator: “…how likely do you think it is, that she will really go to her GP and ask 
for a test?” [after seeing a poster] 
Mrs A1: “Yes, she will go and have a test” 
Mrs C1: “If she is completely well she wont go, she will ignore this piece of paper” 
Mrs B1: “if she knows something about hepatitis B she might go, but for someone 
like me, I wouldn’t understand what it is about, so I just, I wouldn’t even look at it, 
because I don’t understand.” 
Facilitator: “testing is not being promoted for everybody, … it is being promoted for 
people born in Eastern Europe, Asia, Africa, South America, so do you think that 
would be wide enough [to avoid suspicion]?”…… 
Mr A4: “If they understand …it is not just Somali’s it is the rest of the world it is a lot 
of countries, a lot of people, that they accept, it’s just they must understand, I mean 
[interrupted] they are not guinea pig” [laughter] 
Response 
to contact 
tracing 
Facilitator: “What do you think she will be thinking after this discussion with her 
GP?” [regarding contact tracing] 
Mrs C1: “If the doctor told her she can pass it on to other people then she must tell 
them” 
Mrs D1: “I agree” 
Mrs A1: “If she has been told this is dangerous to the family then she has to tell 
them.” 
Facilitator: “Do any of you think that Amina’s husband might blame her for catching 
it, or be angry with her?” 
Participants: [laughter] 
Mrs D2: “He will tell her like, ‘you will be fine, don’t worry’ …..” 
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Mrs ?2: “no no, not embarrassing, he wouldn’t be embarrassed” 
Mrs?2: “he wouldn’t blame her; he would say ‘this is our destiny’” 
Mrs F2: “He will be worrying but he wouldn’t say ‘it is your fault’” 
Mrs C1: “It is easy to say ‘I have hepatitis B’ because it is just jaundice, but to say it is 
transmitted by this way, or sexually, this is harder, it is not what is expected”. 
Facilitator: “….Why do you think people would not [attend for testing]……too busy?” 
Mr F3: “I will tell why, lack of understanding and education, they don’t know how 
risky and how fatal this disease is.  It is now only very few people who have known 
the fatality of this disease and many people will say, ‘oh [inaudible] why bother’, but 
only because they don’t know the risk of the disease.” 
Table 3. Quotes illustrating response to targeted hepatitis B screening and contact tracing. 1 
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Theme Illustrative quote 
Overcoming 
barriers to 
testing and 
contact tracing 
Facilitator: “So do you think it would be possible to have a condition that was 
damaging your liver and you would still feel completely well?” 
Mrs E2: “Yes, because sometimes you have a serious problem and you don’t 
know.” 
Facilitator:  “Would there be anything that would help her to go?  That makes it 
easy for her to go?” [referring to woman receiving advice to attend for a 
hepatitis B test] 
Mrs C1 or A1: “What can make her go maybe her family, if they’re worried 
about, they may encourage her or maybe somebody who has an experience 
about hepatitis B, You know, maybe friends?  Somebody who knows about this 
or had hepatitis themselves may encourage her.” 
Facilitator: “And is there anything else you think we should put in the letter or 
something we should take out of the letter to make it more likely to get Amina 
[fictional character from scenario] to go to her GP?” 
Mrs D1: “If she understands what hepatitis B is, then she will definitely go, so the 
letter must be clear.” 
Mrs A1: “The language that you write the letter in might make a difference, for 
example she might not be able to read English but she might be able to read 
Somali.” 
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Facilitator: “So what exactly should the letter say?” 
Mr F3: “I think it would be emphasised more what is just mentioned here, er, … 
more about the process, saying that this hepatitis B worsening to be a killer or 
fatal at the end, so people telling him how it develops even if you feel well, how 
it comes to an irreversible state or fatal, so if a lot of thought or literature is 
given to that then I think people will understand.” 
Table 4. Quotes illustrating overcoming barriers to engagement. 1 
 2 
 3 
 4 
